• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

First Hand Medical Announces Safe New Therapy for Carpal Tunnel During Pregnancy

Posted on: Friday, 19 May 2006, 15:07 CDT

BURLINGTON, Mass., May 19 /PRNewswire/ -- Cravings for "pickles and ice cream" are not the only things unique to women during pregnancy. Unfortunately, Carpal Tunnel Syndrome (CTS) strikes over 20% of all pregnant women disrupting sleep and inhibiting active use of their hands. It is an ironic twist of fate that just as a woman needs her hands most to prepare for the birth and care of her new born child, her hand use is often curtailed by the pain and numbness associated with CTS. It is even more ironic that the conventional treatments for CTS are not recommended for pregnant women because of the potential threats to the developing baby in the womb. The Carpal Solution, a safe and easy to use therapy, is now being made widely available to consumers and is especially well suited for mothers-to-be. Learn more at http://www.mycarpaltunnel.com/.

Prior to this therapy, conventional treatment options included oral pain medication; restrictive splints that are both uncomfortable, ineffective and result in muscle atrophy; localized steroid injections and invasive surgery in which relapses are common. These are generally not recommended for women during pregnancy due to the potential threat to the fetus. There are few therapeutic areas where patient dissatisfaction with the conventional treatment is higher. An improved non-invasive therapy is sorely needed.

Used by physicians for years, Carpal Solution Therapy is now available directly to consumers under the Carpal Solution brand. As an FDA Class One Device that relieves chronic pain in days, it is particularly well suited for retail pharmacies who like to offer consumers a better first line of defense to common ailments like CTS. Clinically documented, The Carpal Solution is the latest in a new popular class of therapeutic devices that safely treat pain at the source, as opposed to medicinally or through invasive surgery. Retail distribution discussions with leading pharmacies are under way.

Not only does CTS affect pregnant women, but it is reaching epidemic proportions in the population at large, affecting over 75 million people worldwide. There is also a high incidence among sports enthusiasts including skiers, golfers, etc. It most often affects people who engage in repetitive hand movements, however, for pregnant women the primary contributors are hormonal changes, water retention and normal weight gain.

While many women find that their first encounter with CTS occurs during pregnancy, generally they experience regular flare-ups of the condition after pregnancy. Having a reliable therapy that can be easily repeated with no downside is another benefit of that Carpal Solution Therapy offers.

Developed by a muscular skeletal clinician, The Carpal Solution offers a different approach that is more effective and convenient to use. The therapy is self-applied at night, so it fits easily into an active lifestyle and does not hinder daily hand use. It gently reshapes the connective tissue around the Carpal Tunnel and quickly eliminates hand pain. Sufferers get back to a sound night's sleep and regular activities in days.

"The Carpal Solution is a breakthrough in the treatment of CTS, not only because it offers a better first line of defense to stop progression early without side effects, but also because it is safe and so easy for people to self-apply and fits seamlessly into active lifestyles," said Jerome H. Grossman, MD, Director of Healthcare Delivery at Harvard and Chair of Eureka Medical's Expert Advisory Board. Eureka Partners I, LLC recently funded a first round venture investment in First Hand Medical to commercialize the Carpal Solution Therapy.

First Hand Medical is a leading supplier of a new class of products focused in sectors where the healthcare system has fallen short of consumer expectations. First Hand teams with physicians to design products for well informed health consumers who actively seek practical solutions that work. Contact: Donna Voiland, donna@mycarpaltunnel.com, Phone: 781-229-5878, http://www.mycarpaltunnel.com/

Eureka Partners I, LLC is a venture firm affiliated with Eureka Medical, the Leading Medical Inventor Network. Eureka Partners I, LLC recently funded First Hand Medical with a First Round Investment to commercialize the Carpal Solution. Eureka Medical evaluates hundreds of medical inventions per year from physician inventors. These devices are screened by an expert medical Advisory Board. The Carpal Solution was selected as the Top Home Health Product. http://www.eurekamed.com/

First Hand Medical

CONTACT: Donna Voiland of First Hand Medical, +1-781-229-5878,donna@mycarpaltunnel.com

Web site: http://www.mycarpaltunnel.com/http://www.eurekamed.com/

Source: PRNewswire

More News in this Category